Spine BioPharma

New York, United States

Spine BioPharma develops a non-surgical solution for back pain that eliminates pain and restores functionality.

$13.5M raised

Dec 2024

Undisclosed

Biotechnology Medical Pharmaceutical

Top Investors

Pacira Pharmaceuticals Viscogliosi Brothers Vulcan Capital Cercano Management

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Spine BioPharma

How much funding has Spine BioPharma raised?

Spine BioPharma has raised $13.5M in total funding. The most recent round was Undisclosed. The last funding was announced in December 2024.

Who are Spine BioPharma's investors?

Spine BioPharma's investors include Pacira Pharmaceuticals, Viscogliosi Brothers, Vulcan Capital, Cercano Management.

Where is Spine BioPharma headquartered?

Spine BioPharma is headquartered in New York, United States.

What does Spine BioPharma do?

Spine BioPharma develops a non-surgical solution for back pain that eliminates pain and restores functionality.

What stage is Spine BioPharma at?

Spine BioPharma is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 18, 2024.

MLA

"Spine BioPharma — Funding & Investors." VCBacked, December 18, 2024, https://www.vcbacked.co/company/spine-biopharma. Accessed July 5, 2026.

APA

VCBacked. (2024). Spine BioPharma — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/spine-biopharma

Wikipedia (cite web)

{{cite web |title=Spine BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/spine-biopharma |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 18, 2024.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K